Gynecologic Cancer | Tumor

CURE’s gynecologic cancer page is an extensive resource of cancer information featuring the latest gynecologic cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on gynecologic cancer.

Cancer Survivors Obtain Similar Immune Response to HPV Vaccine as General Population

December 16th 2021

The vaccine, which protects patients from seven different strains related to HPV-related cancers, may be considered part of routine oncology care for survivors.

Keytruda Receives FDA Approval for Firstline Treatment of Certain Patients With Cervical Cancer

October 13th 2021

The FDA approved Keytruda for use with chemotherapy with or without bevacizumab, for the treatment of a subset of patients with cervical cancer.

Effects of Early Menopause From Cancer Treatment May Be Eased With Hormone Replacement Therapy

October 6th 2021

Side effects from early-onset menopause from medical treatments may be mitigated with hormone replacement therapy.

FDA Approves Tivdak for Metastatic/Recurrent Cervical Cancer

September 20th 2021

Tivdak is a targeted therapy that showed promising results for patients with pretreated metastatic or recurrent cervical cancer.

Standard Screening Practices May Highlight Disparities in Endometrial Cancer

August 5th 2021

Transvaginal ultrasonography may inaccurately measure uterine lining in Black women, highlighting the potential to assess its use on a case-by-case basis.

FDA Approves Keytruda/Lenvima Combo for Advanced Endometrial Cancer

July 22nd 2021

The Food and Drug Administration approved Keytruda plus Lenvima for patients with advanced endometrial carcinoma whose disease had progressed after previous systemic therapy and are not candidates for surgery or radiation.

FDA Grants Accelerated Approval to Jemperli for Endometrial Cancer

April 22nd 2021

Jemperli (dostarlimab) received accelerated approval from the Food and Drug Administration for the treatment of patients with recurrent or advanced endometrial cancer whose disease has progressed on, or following, prior treatment with a platinum-containing chemotherapy and whose cancers have a specific genetic biomarker known as deficient mismatch repair.

Targeted Therapies Take Aim at Endometrial Cancer

March 17th 2021

As more is learned about the biology of endometrial cancer, new treatment possibilities emerge.

7 Recent Updates in the Field of Women's Cancers

March 8th 2021

In honor of International Women’s Day, CURE® compiled some recent news and updates in women’s cancers that patients, survivors and caregivers may have missed.

Radiation After Surgery May Lower the Risk for Disease Spread in Uterine Carcinosarcomas

February 9th 2021

Women who underwent radiation after cancer surgery had improved distant metastases-free survival rates, although this benefit was not evident in overall survival.